| Cat.No. | Name | Information |
|---|---|---|
| M2952 | PMSF | PMSF is an irreversible serine/cysteine protease inhibitor. PMSF is commonly used in the preparation of cell lysates. |
| M3651 | Aprotinin | Aprotinin is a small protein serine protease inhibitor which is used to reduce perioperative blood loss and transfusion. |
| M5219 | AEBSF HCl | AEBSF HCl is an irreversible inhibitor of serine proteases, such as chymotrypsin, kallikrein, plasmin, thrombin, and trypsin. |
| M42612 | PCSK9-IN-14 | PCSK9-IN-14 is a potent PCSK9 inhibitor. |
| M42611 | PKSI-527 | PKSI-527 is a new, highly selective plasma kallikrein inhibitor. |
| M42610 | PCSK9-IN-18 | PCSK9-IN-18 is a potent PCSK9 inhibitor with a KD value of <200 nM. |
| M42609 | Dim16 | Dim16 is a dual PCSK9/HMG-CoAR inhibitor, with an IC50 value of 19 nM for PCSK9. |
| M42608 | PCSK9-IN-15 | PCSK9-IN-15 is a potent inhibitor of proprotein convertase subtilisin/kexin 9 (PCSK9, KD <200 nM). |
| M42607 | AP-C2 | AP-C2 is a potent guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII) inhibitor with a pIC50 of 5.2. |
| M42606 | Benzamidine hydrochloride hydrate | Benzamidine hydrochloride hydrate is a reversible competitive trypsin-like serine proteases inhibitor with Kis of 20, 21, 97, 110, 320 and 750 μM against Tryptase, Trypsin, uPA, Factor Xa, Thrombin and tPA, respectively. |
| M40917 | Rivulariapeptolides 1121 | Rivulariapeptolides 1121 is a potent and selective serine protease inhibitor with IC50 values of 35.52 nM, 13.24 nM, and 48.05 nM for tryptic coagulase, elastase, and proteinase K, respectively. |
| M40916 | Rivulariapeptolides 1185 | Rivulariapeptolides 1185 is a potent and selective serine protease inhibitor with IC50 values of 13.17 nM, 23.59 nM, and 55.26 nM for tryptic coagulase, elastase, and proteinase K, respectively. |
| M40915 | Rivulariapeptolides 988 | Rivulariapeptolides 988 is a potent and selective serine protease inhibitor with IC50 values of 95.46 nM, 15.29 nM and 85.50 nM for tryptic coagulase, elastase and proteinase K, respectively. |
| M40914 | Rivulariapeptolides 1155 | Rivulariapeptolides 1155 is a potent serine protease inhibitor with IC50 values of 41.84 nM, 4.94 nM, and 56.54 nM for chymotrypsin, elastase, and proteinase K, respectively. |
| M30522 | FOY 251 free base | FOY 251 free base, an anti-proteolytic active metabolite of Camostate, acts as a proteinase inhibitor. FOY 25 free base inhibits SARS-CoV-2 infection in cells assay. |
| M30043 | TPCK | TPCK (L-1-Tosylamido-2-phenylethyl chloromethyl ketone; L-TPCK) is a potent serine protease inhibitor that reacts with the retinoblastoma protein (RB)-binding core of HPV-18 E7 protein and abolish its RB-binding capability. TPCK is able to modify E7 protein in live keratinocytes following its addition to the culture medium. |
| M29739 | ZK824190 hydrochloride | ZK824190 hydrochloride is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively. |
| M29715 | VD2173 | VD2173 is a side chain cyclized macrocyclic peptide inhibitor of HGF-activating serine proteases. VD2173 potently inhibits matriptase and hepsin. VD2173 can be used for the research of lung cancer. |
| M29468 | Flizasertib | Flizasertib is a serine/threonine kinase inhibitor. |
| M29454 | ZK824190 | ZK824190 is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively. |
| M29315 | Feniralstat | Feniralstat (compound 30), a pyrazole derivative, is a potent kallikrein inhibitor with an IC50 of 6.7 nM for Human plasma kallikrein (pKal). Feniralstat has no inhibition on Human KLKl, Human FXIa, Human Factor Xlla (all IC50>40 μM). |
| M29268 | WNK-IN-1 | WNK-IN-1 (compound 7) is a ATP noncompetitive With-No-Lysine (WNK) kinase inhibitor (IC50=95 nM). WNK-IN-1 can be used to regulate cardiovascular homeostasis. |
| M29266 | WNK-IN-11-d3 | WNK-IN-11-d3 is an orally active, selective and potent With-No-Lysine (WNK) kinase inhibitor. WNK-IN-11-d3 is effective at regulating cardiovascular homeostasis. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
